Rhode Island Pharmacists Association - Links to COVID-19 resources- Patient Care

RIPA COVID-19 Pharmacists Discussion Forum.
Add your questions/ thoughts and our team will try to respond. Click "subscribe" to get updates on the forum discussions.

Forum subscriptions (daily digest emails)

You can subscribe for updates in a particular forum or forum topic. Go to forum/topic page to subscribe

Back to topics

Links to COVID-19 resources- Patient Care

Show oldest replies on top

Subscribe to topic

<< First < Prev 1 2 Next > Last >>

Tuesday, April 21, 2020 6:25 PM

Quote

Reply # 8920210 on 8862277

Anonymous

below is the link to NIH/HHS guidelines for treatment of COVID-19

These Treatment Guidelines have been developed to inform clinicians how to care for patients with COVID-19

The COVID-19 Treatment Guidelines Panel (the Panel) does not recommend the use of any agents for pre-exposure prophylaxis (PrEP) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outside of the setting of a clinical trial (AIII).
The Panel does not recommend the use of any agents for post-exposure prophylaxis (PEP) against SARS-CoV-2 infection outside of the setting of a clinical trial (AIII).
The Panel recommends no additional laboratory testing and no specific treatment for persons with suspected or confirmed asymptomatic or presymptomatic SARS-CoV-2 infection (AIII).
At present, no drug has been proven to be safe and effective for treating COVID-19. There are insufficient data to recommend either for or against the use of any antiviral or immunomodulatory therapy in patients with COVID-19 who have mild, moderate, severe, or critical illness

https://www.covid19treatmentguidelines.nih.gov/introduction/

Last modified: Tuesday, April 21, 2020 10:29 PM | Anonymous member (Administrator)

Sunday, April 19, 2020 11:06 AM

Quote

Reply # 8908964 on 8862277

Anonymous member (Administrator)

Below are articles discussing COVID-19 associated coagulopathy, typical presentation, lab findings, prognosis, treatment and differentiating factors from (DIC).

ASH
https://hematology.org/covid-19/covid-19-and-vte-anticoagulation
https://hematology.org/covid-19/covid-19-and-coagulopathy

ISTH
https://onlinelibrary.wiley.com/doi/10.1111/jth.14810

ThrombosisUK

https://thrombosisuk.org/covid-19-thrombosis.php

Monday, April 13, 2020 10:45 AM

Quote

Reply # 8896108 on 8862277

Anonymous

On April 11th, the IDSA published guidelines on treatment and management of patients with COVID-19.

These guidelines provide supporting data and expert opinion on a lot of topics including hydroxychloroquine+azithromycin, lopinavir+ritonavir, corticosteroids, tocilizumab, and convalescent plasma.

https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/

Thursday, April 09, 2020 2:05 PM

Quote

Reply # 8890019 on 8862277

Anonymous

For those wondering about the risks and benefits of common canister policies, here is a good article that briefly addresses it!

https://www.mdedge.com/chestphysician/article/113875/critical-care/common-canister-policy-devil-details/page/0/1

Thursday, April 09, 2020 9:46 AM

Quote

Reply # 8889525 on 8862277

Anonymous

The IDSA has been making podcasts on COVID-19 since the beginning of the pandemic. They aren't updates but rather 30 minutes long discussions with infectious disease specialists from around the world. They're available on Sound Cloud, Apple Podcasts, and Spotify!

https://www.idsociety.org/Podcasts/

Wednesday, April 08, 2020 1:28 PM

Quote

Reply # 8887661 on 8862277

Anonymous

For anyone with questions about the increase in Aggregate Production Quotas for schedule drugs, the link below brings you to the DEA press release for more information:

https://www.dea.gov/press-releases/2020/04/07/dea-takes-additional-steps-allow-increased-production-controlled

Wednesday, April 08, 2020 9:25 AM

Quote

Reply # 8887113 on 8862277

Anonymous

With the new online process for ordering a specimen sample, our patients and providers will likely have questions.

The link below brings you to a PDF on the steps on how providers can use the Doctor Portal to schedule COVID-19 tests for patients.

https://health.ri.gov/publications/instructions/COVID-Ordering-Instructions.pdf?mc_cid=c5ddd11cf0&mc_eid=1a1909667b

Tuesday, April 07, 2020 1:35 PM

Quote

Reply # 8883976 on 8862277

Anonymous

For anyone with questions about QTc prolongation risk associated with hydroxychloroquine and azithromycin, the ACC has good in depth information on the topic.

The link brings you to an article with recommendations and it includes a section on outpatient monitoring.

https://www.acc.org/latest-in-cardiology/articles/2020/03/27/14/00/ventricular-arrhythmia-risk-due-to-hydroxychloroquine-azithromycin-treatment-for-covid-19

Tuesday, April 07, 2020 11:32 AM

Quote

Reply # 8883720 on 8862277

Anonymous

Link to a great resource from WHO myth busting common myths that your patients may ask you:

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-for-public/myth-busters

Friday, April 03, 2020 11:09 AM

Quote

Reply # 8877158 on 8862277

Anonymous

If anyone has patients, friends, or family members, who are having a hard time paying for insulin at this time, you can call the Lilly Diabetes Solution Center at 833-808-1234.

They are helping patients who have lost their jobs or aren't getting paid at this time with insulin costs.

The link below has more detailed information:

https://mailchi.mp/health/respiratory-care-guidance-1701829?mc_cid=2d6f44f183&mc_eid=e661a06c3f

<< First < Prev 1 2 Next > Last >>

Rhode Island Pharmacists Association ∙ 1643 Warwick Ave PMB 113, Warwick, RI 02889 ∙ Phone: (401) 684-1874

RIPA COVID-19 Pharmacists Discussion Forum. Add your questions/ thoughts and our team will try to respond. Click "subscribe" to get updates on the forum discussions.

Links to COVID-19 resources- Patient Care

RIPA COVID-19 Pharmacists Discussion Forum.
Add your questions/ thoughts and our team will try to respond. Click "subscribe" to get updates on the forum discussions.